Hubei Goto Biopharm Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Market Capitalization	3,568	2,266	1,859	2,648	3,112	4,729
Market Cap Growth	79.09%	21.86%	-29.78%	-14.93%	-34.18%	-
Enterprise Value	4,891	3,527	2,838	3,321	3,500	4,781
Last Close Price	31.00	19.69	16.13	22.95	26.98	40.79
PE Ratio	-	-	-	115.10	77.42	60.37
PS Ratio	5.89	3.74	3.47	4.68	5.15	8.00
PB Ratio	3.92	2.49	1.83	2.59	3.17	5.71
P/TBV Ratio	4.62	2.93	2.13	2.94	3.52	6.07
P/OCF Ratio	86.94	55.22	-	38.86	-	81.52
EV/Sales Ratio	7.81	5.82	5.29	5.86	5.79	8.09
EV/EBITDA Ratio	93.39	43.12	100.45	62.18	50.18	55.11
EV/EBIT Ratio	-	-	-	123.29	77.00	74.15
Debt / Equity Ratio	1.43	1.43	1.12	0.77	0.79	0.20
Debt / EBITDA Ratio	15.88	15.88	39.68	14.25	10.60	1.84
Net Debt / Equity Ratio	1.33	1.33	0.98	0.59	0.32	-0.06
Net Debt / EBITDA Ratio	14.84	14.84	35.05	11.31	4.54	-0.56
Net Debt / FCF Ratio	-9.68	-9.68	-2.98	-1.77	-0.73	1.47
Asset Turnover	0.22	0.22	0.21	0.25	0.37	0.59
Inventory Turnover	1.22	1.22	1.12	1.09	1.16	1.56
Quick Ratio	0.34	0.34	0.44	0.61	1.26	1.37
Current Ratio	0.94	0.94	0.95	1.27	2.11	2.58
Return on Equity (ROE)	-8.49%	-8.49%	-3.11%	2.12%	4.37%	11.41%
Return on Assets (ROA)	-0.74%	-0.74%	-0.35%	0.74%	1.73%	4.00%
Return on Invested Capital (ROIC)	-1.58%	-1.63%	-0.81%	1.84%	4.38%	8.12%
Return on Capital Employed (ROCE)	-1.70%	-1.70%	-0.70%	1.50%	3.00%	7.30%
Earnings Yield	-2.06%	-3.24%	-1.48%	0.87%	1.29%	1.66%
FCF Yield	-3.51%	-5.53%	-17.87%	-12.88%	-13.88%	-0.70%
Dividend Yield	-	-	-	0.07%	-	0.33%
Payout Ratio	-	-	-	26.49%	66.92%	9.67%
Buyback Yield / Dilution	0.29%	0.29%	0.05%	-0.13%	-8.77%	-22.87%
Total Shareholder Return	0.29%	0.29%	0.05%	-0.06%	-8.77%	-22.54%